Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models. (Q39247909)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models. |
scientific article |
Statements
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models (English)
Jill M Spoerke
Carol O'Brien
Ling Huw
Hartmut Koeppen
Jane Fridlyand
Rainer K Brachmann
Peter M Haverty
Ajay Pandita
Sankar Mohan
Deepak Sampath
Lori S Friedman
Leanne Ross
Garret M Hampton
Lukas C Amler
David S Shames
7 November 2012